News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Otsuka Pharmaceutical Co., Ltd.'s Antipsychotic Medication Approved For Marketing In Europe


10/19/2005 5:08:42 PM

Otsuka Pharmaceutical has announced that it has received marketing approval for "Abilify," its atypical antipsychotic medication, from the European Commission.

Read at JCN Newswire

Related News

comments powered by Disqus
   
Psychosis

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES